Candel Therapeutics, Inc.

CADL · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$86,963$100,687$92,165$102,654
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$3,171$2,921$983$1,150
Total Curr. Assets$90,134$103,608$93,148$103,804
Property Plant & Equip (Net)$3,113$2,049$2,433$2,733
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$266$266$0
Tax Assets$0$0$0$0
Other NC Assets$351$45$58$329
Total NC Assets$3,464$2,360$2,757$3,062
Other Assets$0$0$0$0
Total Assets$93,598$105,968$95,905$106,866
Liabilities
Payables$1,118$1,953$760$237
Short-Term Debt$4,662$7,298$9,752$10,461
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$5,149$5,464$9,557$26,831
Total Curr. Liab.$10,929$14,715$20,069$37,529
LT Debt$1,572$1,043$1,161$3,010
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$973$0$0$0
Total NC Liab.$2,545$1,043$1,161$3,010
Other Liabilities$0$0$0$0
Cap. Leases$0$698$837$973
Total Liabilities$13,474$15,758$21,230$40,539
Equity
Pref Stock$0$0$0$0
Common Stock$550$549$493$469
Retained Earnings-$200,891-$189,622-$184,826-$192,205
AOCI$0$0$0-$0
Other Equity$280,465$279,283$259,008$258,063
Total Equity$80,124$90,210$74,675$66,327
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$93,598$105,968$95,905$106,866
Net Debt-$80,729-$92,346-$81,252-$89,183
Candel Therapeutics, Inc. (CADL) Financial Statements & Key Stats | AlphaPilot